Determinants of Incidence of Loss to Follow-up in Tuberculosis Patients at Bintuni Health Center

Henderyana Arrang Pantan; Hasmi; Sarce Makaba; Arius Togodly; Novita Medyati; Rosmin Mariati Tingginehe

doi:10.55927/fjst.v5i4.48

Authors

Henderyana Arrang Pantan Master of Public Health Study Program, Faculty of Public Health, Cenderawasih University of Jayapura
Hasmi Department of Master of Public Health Program, Faculty of Public Health, Cenderawasih University of Jayapura
Sarce Makaba Department of Master of Public Health Program, Faculty of Public Health, Cenderawasih University of Jayapura
Arius Togodly Department of Master of Public Health Program, Faculty of Public Health, Cenderawasih University of Jayapura
Novita Medyati Department of Master of Public Health Program, Faculty of Public Health, Cenderawasih University of Jayapura
Rosmin Mariati Tingginehe Department of Master of Public Health Program, Faculty of Public Health, Cenderawasih University of Jayapura

DOI:

https://doi.org/10.55927/fjst.v5i4.48

Keywords:

Tuberculosis, LTFU, Drug Side Effects, Treatment

Abstract

This study aims to analyze factors related to the incidence of Loss To Follow Up (LTFU) in TB patients at the Bintuni Health Center, Teluk Bintuni Regency. The study used an analytical observational design with a cross-sectional design based on secondary data recorded in the TB 03 register. The study population is all TB patients who started treatment in the period from January 2024 to August 2025, with a total of 245 patients sampled. The results showed that the relationship between age (p=0.260), sex (p=0.998), distance traveled (p=0.967), PMO (p=0.536), and ethnicity (p=0.141) was not significant with the incidence of LTFU. Meanwhile, the variables of education (p=0.000), employment (p=0.000), and drug side effects (p=0.000) were significantly related to the incidence of LTFU. Drug side effect variables are the most dominant factor in the incidence of LTFU

References

Afriani, Dina, and Edianto Edianto. 2024. “Analysis of Adherence Treatment Factors in Drug-Resistant Tuberculosis Patients with Acid-Resistant Bacillus Conversion.” Jurnal Kesehatan Pasak Bumi Kalimantan 7(2): 168. doi:10.30872/j.kes.pasmi.kal.v7i2.16481.

Aminah, Nenden Siti, and Ratna Djuwita. 2021. “Tren dan Faktor yang Berhubungan dengan Keberhasilan Pengobatan Pasien TB MDR Paduan Jangka Pendek di Indonesia 2017–2019.” Pro Health Jurnal Ilmiah Kesehatan 3(1): 109–17.

Anisah, Anisah, Dyah Wulan Sumekar, and Endang Budiarti. 2021. “Hubungan Demografi Dan Komorbid Dengan Kejadian Tuberkulosis Resisten Obat (TB RO).” Jurnal Ilmiah Kesehatan Sandi Husada 10(2): 568–74. doi:10.35816/jiskh.v10i2.655.

Dessritina, Pesona, Ravi Masitah, Irzal Fanany, Teuku Muhammad Rafsanjani, Eva Flourentina Kusumawati, and Maiza Duana. 2025. “Analisis Ketahanan Hidup Pada Pasien TB-MDR (Tuberkulosis Multi-Drug Resistant) Dengan Komorbid DM Dan/Atau HIV Di Kota Medan, Sumatera Utara.” Jurnal Penelitian Inovatif 5(3): 2331–40. doi:10.54082/jupin. 1702.

Dinkes Provinsi Papua. 2025. “Laporan Kinerja Dinas Kesehatan Provinsi Papua.” Lkj Provinsi Papua 7(2).

Fitriana, Grace. 2022. “Faktor-Faktor Yang Mempengaruhi Keberhasilan Pengobatan Pasien Tuberkulosis Resistan Obat Di RSUP Dr. Sardjito Yogyakarta.” Journal repository.

Hasmi. 2023. Metode Penelitian Epidemiologi Edisi 2.

Hasmi and Sarce Makaba. 2024. “Risk Attribute Analysis and Risk of Adherence to Taking Medication for Pulmonary TB Patients at the Jayapura Regency Office.” 3(11): 2489–98.

Kemenkes RI. 2024a. Juknis Penatalaksanaan Tuberkulosis Resisten Obat Di Indonesia.

Kemenkes RI. 2024b. Petunjuk Teknis Penatalaksanaan TBC RO di Indonesia.

Laili, Fitrianur, Farida Murtiani, and Sudarto Ronoatmodjo. 2024. “Ko-Infeksi TB-HIV terhadap kegagalan pengobatan pasien tuberkulosis resisten obat di Indonesia.” The Indonesian Journal Of Infection Diseases 10(2). doi: https://doi.org/10.32667/ijid.v10i2.309

Mahartati, Ni Made Nujita, and Syahrizal Syarif. 2024. “Faktor Risiko Kegagalan Pengobatan Tuberkulosis: Systematic Review.” Media Publikasi Promosi Kesehatan Indonesia (MPPKI) 7(4): 899–906. doi:10.56338/mppki.v7i4.5157.

Mega, Shinta, Sabania Injar; Gama, and Adam Ramadhan M. 2016. “Kajian Pengobatan dan Kepatuhan Pasien Multidrug-Resistant Tuberculosis (MDR-TB) di RSUD A. W. Sjahranie Samarinda.” Prosiding Seminar Kefarmasian.

Nurwajdaini Nurfa. 2022. 2 tesis “Hubungan Faktor Demografis Dengan Keberhasilan Pengobatan Pasien TB-RO Di RSUD Dr.Saiful Anwar Malang.”

Priscillia Ryani Tutuhatunewa, Lukman Hardia, Irwandi. 2024. “PENGARUH SOSIODEMOGRAFI TERHADAP KEBERHASILAN PENGOBATAN PASIEN TB-RO DI RSUD DR. J. P. WANANE.” Jurnal Kesehatan Tambusai 5 (September): 9280–88.

Ruru, Yacob, Nur Nasry, Alimin Maidin, and Andi Zulkifli. 2017. “Model of Risk Factors of Multidrug-Resistant Tuberculosis ( MDR-TB ) in RSUD Dok II Jayapura.” 4531(9): 237–48.

Serpa, Jose A., Larry D. Teeter, James M. Musser, and Edward A. Graviss. 2009. “Tuberculosis Disparity between US-Born Blacks and Whites, Houston, Texas, USA.” Emerging Infectious Diseases 15(6): 899–904. doi:10.3201/eid1506.081617.

Setiawan, Budi, Tri Yunis Miko Wahyono, Dwi Oktavia, Fakultas Kesehatan Masyarakat, Universitas Indonesia, and Dinas Kesehatan Provinsi DKI Jakarta. 2024. “Hubungan Kepatuhan dan Riwayat Pengobatan terhadap Keberhasilan Pengobatan Tuberkulosis Resistan Obat dengan Paduan Obat Jangka Pendek 9-11 Bulan di Provinsi DKI Jakarta.” Journal of Mandalika Literature 5(3): 210–21.

Womsiwor, P.S, Marlina Flassy, Usman Idris, Simon Abdi, and K Frank. 2024. “Science Midwifery Traditional Medicine of the Biak Tribe in Opuri Village, Biak Regency, Papua.” Science Midwifery 12(2): 2721–9453.

World Health Organization. 2025. Blood Global Tuberculosis Report. doi:978 92 4 156450 2.

Wulandari, Elizabeth. 2024. “Determinan Kegagalan Pengobatan Pada Pasien Tuberkulosis Sensitif Obat Dewasa Di Provinsi Jawa Tengah Tahun 2022.” Jurnal Epidemiologi Kesehatan Indonesia 8(1). doi:10.7454/epidkes.v8i1.1100.